Merus NV
MRUS95.160USD
-0.020-0.02%
종가 11/06, 16:00（ET）시세는 15분 지연됩니다
7.22B시가총액
손실P/E TTM
자세한 내용은 Merus NV 회사
Merus NV is the Netherlands - based biotechnology company, concentrated on developing differentiating therapeutics for cancer patients. The product programs in the Merus pipeline are based on the Multiclonics format. Its products are designed to bind to multiple targets, and are manufactured with features for anti-cancer effects against the complex mechanisms that drive cancer. Company's products engage cancer antigens and harness the power of the immune system to kill tumor cells by utilizing technology platform. One of the drug zenocutuzumab (Zeno), a Biclonics antibody, concentrates on helping patients with lung, pancreatic and other types of solid tumors. The company operates in the Netherlands and United States.
Merus NV 정보
종목 코드 MRUS
회사 이름Merus NV
상장일May 19, 2016
CEODr. Sven Ante (Bill) Lundberg, M.D.
직원 수260
유형Ordinary Share
회계 연도 종료May 19
주소Yalelaan 62
도시UTRECHT
증권 거래소NASDAQ Global Market Consolidated
국가Netherlands
우편 번호3584 CM
전화310302538800
웹사이트https://merus.nl/
종목 코드 MRUS
상장일May 19, 2016
CEODr. Sven Ante (Bill) Lundberg, M.D.
Merus NV의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Sven Ante (Bill) Lundberg, M.D.
Dr. Sven Ante (Bill) Lundberg, M.D.
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
198.74K
+55.46%
Dr. Anand Mehra, M.D.
Dr. Anand Mehra, M.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Peter B. Silverman, J.D.
Mr. Peter B. Silverman, J.D.
Chief Operating Officer, General Counsel, Chief Intellectual Property Officer and Head of US Legal
Chief Operating Officer, General Counsel, Chief Intellectual Property Officer and Head of US Legal
--
--
Ms. Sherri Spear
Ms. Sherri Spear
Investor Relations and Corporate Communications
Investor Relations and Corporate Communications
--
--
Mr. Jason Haddock
Mr. Jason Haddock
Director
Director
--
--
Dr. Fabian Zohren, M.D., Ph.D
Dr. Fabian Zohren, M.D., Ph.D
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Maxine Gowen, Ph.D.
Dr. Maxine Gowen, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Leonard (Len) Kanavy
Mr. Leonard (Len) Kanavy
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Victor Sandor, M.D.
Dr. Victor Sandor, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Gregory D. (Greg) Perry
Mr. Gregory D. (Greg) Perry
Chief Financial Officer
Chief Financial Officer
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Sven Ante (Bill) Lundberg, M.D.
Dr. Sven Ante (Bill) Lundberg, M.D.
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
198.74K
+55.46%
Dr. Anand Mehra, M.D.
Dr. Anand Mehra, M.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Peter B. Silverman, J.D.
Mr. Peter B. Silverman, J.D.
Chief Operating Officer, General Counsel, Chief Intellectual Property Officer and Head of US Legal
Chief Operating Officer, General Counsel, Chief Intellectual Property Officer and Head of US Legal
--
--
Ms. Sherri Spear
Ms. Sherri Spear
Investor Relations and Corporate Communications
Investor Relations and Corporate Communications
--
--
Mr. Jason Haddock
Mr. Jason Haddock
Director
Director
--
--
Dr. Fabian Zohren, M.D., Ph.D
Dr. Fabian Zohren, M.D., Ph.D
Chief Medical Officer
Chief Medical Officer
--
--
수익 분석
데이터 없음
데이터 없음
사업별
지역별
데이터 없음
주식 보유 통계
마지막 업데이트: Fri, Aug 15
마지막 업데이트: Fri, Aug 15
주주
주주 유형
주주
주주
비율
Fidelity Management & Research Company LLC
8.20%
Paradigm BioCapital Advisors LP
5.65%
RTW Investments L.P.
5.27%
Wellington Management Company, LLP
4.91%
Commodore Capital LP
4.65%
기타
71.32%
주주
주주
비율
Fidelity Management & Research Company LLC
8.20%
Paradigm BioCapital Advisors LP
5.65%
RTW Investments L.P.
5.27%
Wellington Management Company, LLP
4.91%
Commodore Capital LP
4.65%
기타
71.32%
주주 유형
주주
비율
Investment Advisor/Hedge Fund
36.78%
Hedge Fund
34.50%
Investment Advisor
25.54%
Corporation
1.93%
Venture Capital
1.77%
Research Firm
1.13%
Private Equity
0.93%
Individual Investor
0.37%
Pension Fund
0.36%
기관 주식 보유
마지막 업데이트: Wed, Oct 1
마지막 업데이트: Wed, Oct 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q3
431
77.28M
101.92%
-5.29M
2025Q2
411
75.46M
99.77%
-10.50M
2025Q1
420
74.82M
101.12%
-10.15M
2024Q4
398
74.69M
108.18%
-7.45M
2024Q3
373
72.99M
107.03%
-6.71M
2024Q2
355
69.91M
103.77%
+7.77M
2024Q1
315
57.35M
97.63%
-5.32M
2023Q4
282
57.36M
99.41%
-5.55M
2023Q3
268
57.60M
100.50%
+2.76M
2023Q2
260
49.90M
100.83%
+114.35K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Fidelity Management & Research Company LLC
6.22M
8.2%
+593.98K
+10.56%
Jun 30, 2025
Paradigm BioCapital Advisors LP
4.28M
5.65%
+727.89K
+20.48%
Jun 30, 2025
RTW Investments L.P.
4.00M
5.28%
-168.84K
-4.05%
Jun 30, 2025
Wellington Management Company, LLP
3.73M
4.92%
-991.45K
-21.01%
Jun 30, 2025
Commodore Capital LP
3.52M
4.65%
-947.84K
-21.19%
Jun 30, 2025
Deerfield Management Company, L.P.
3.38M
4.47%
+210.70K
+6.64%
Jun 30, 2025
Avoro Capital Advisors LLC
3.16M
4.16%
+155.56K
+5.19%
Jun 30, 2025
T. Rowe Price Associates, Inc.
2.26M
2.98%
+1.17M
+106.44%
Jun 30, 2025
Holocene Advisors, LP
2.23M
2.94%
+351.62K
+18.77%
Jun 30, 2025
Westfield Capital Management Company, L.P.
2.04M
2.69%
+541.17K
+36.05%
Jun 30, 2025
더 보기
관련 ETF
마지막 업데이트: Thu, Nov 6
마지막 업데이트: Thu, Nov 6
이름
비율
Harbor Health Care ETF
4.61%
ALPS Medical Breakthroughs ETF
4.1%
Tema Oncology ETF
3.91%
AltShares Merger Arbitrage ETF
3.3%
NYLI Merger Arbitrage ETF
3.1%
Goldman Sachs Hedge Industry VIP ETF
2.89%
First Trust IPOX Europe Equity Opportunities ETF
2.59%
Simplify Health Care ETF
2.48%
Invesco Dorsey Wright Healthcare Momentum ETF
1.5%
AltShares Event-Driven ETF
1.39%
더 보기
Harbor Health Care ETF
비율4.61%
ALPS Medical Breakthroughs ETF
비율4.1%
Tema Oncology ETF
비율3.91%
AltShares Merger Arbitrage ETF
비율3.3%
NYLI Merger Arbitrage ETF
비율3.1%
Goldman Sachs Hedge Industry VIP ETF
비율2.89%
First Trust IPOX Europe Equity Opportunities ETF
비율2.59%
Simplify Health Care ETF
비율2.48%
Invesco Dorsey Wright Healthcare Momentum ETF
비율1.5%
AltShares Event-Driven ETF
비율1.39%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
